Skip to content

Dr. Ilse Van Genechten

Active
Private limited companyfounded 2024active for 2 yearsWeynesbaan 179, 2580 Putte, BelgiumKBO/BCE: BE 1015.121.628
Summary

Dr. Ilse Van Genechten has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €43,551 and a net result of €40,551. Its solvency ranks better than 38% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 15-10-2024 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.366.022.614 2580 Putte, since 15-10-2024
Financial year end
31 December
Peppol
Reachable since 29-08-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€58,992
▲ 27×
Turnover
≈ €130,000
estimated
Profit
€40,551
▲ 24×
Equity
€43,551
▲ 11×
Total assets
€90,775
▲ 962%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.25, cash €52,919Figures for financial year 2025 (filed on 01-04-2026)Equity €43,551 (48.0% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 68% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 73+3
equity 48.0% of total assets
Liquidity 75-10
short-term debt 50.4% · cash 58.3%
Profitability 100+7
return on assets 44.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 11-2025: < 0.1% 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026highest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €4,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.25 (2.22 in 2024), below the usual 1.5. Short-term debt is 50.4% and cash 58.3% of total assets. 52% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 38% of them on solvency, 56% on liquidity, 80% on profitability and 99% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.25, cash €52,919
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 01-04-2026)
NBB · annual accounts
lowers risk · Equity €43,551 (48.0% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-04-2026, 121 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
121 days early
2024
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 82 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,000 · Appointment: VAN GENECHTEN Ilse (director)
All 3 events

Comparable companies

These companies have the same main activity as Dr. Ilse Van Genechten: general medical practice (NACE 86210). They are comparable in size and age: total assets between €83,100 and €98,800, founded in 2024.

CompanyTotal assetsGross margin
Dr. Ilse Van Genechten Putte€90,775€58,992
MM health Haacht€92,792€56,950
Dr. Sanne Ceuppens Genk€83,118€59,400
Et-M Liège€89,817€63,733
SHIFAMED Sint-Joost-ten-Node€83,465€54,768
Huisarts Dekock Frederik Vilvoorde€98,754€60,324
JYG Med Nivelles€83,564€56,841
Full comparison

Key facts about Dr. Ilse Van Genechten

What is the company number of Dr. Ilse Van Genechten?
The company number of Dr. Ilse Van Genechten is 1015.121.628. The VAT number is the same number with BE in front: BE 1015.121.628.
Where is Dr. Ilse Van Genechten based?
The registered office is at Weynesbaan 179, 2580 Putte.Company details
What does Dr. Ilse Van Genechten do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Ilse Van Genechten?
The legal form of Dr. Ilse Van Genechten is Private limited company (BV).
When was Dr. Ilse Van Genechten founded?
Dr. Ilse Van Genechten was founded on 15-10-2024.
Is Dr. Ilse Van Genechten still active?
Yes, Dr. Ilse Van Genechten is an active enterprise in the KBO register.
What is the turnover of Dr. Ilse Van Genechten?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €58,992 and 32 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.Financials
Is Dr. Ilse Van Genechten profitable?
In financial year 2025, Dr. Ilse Van Genechten made a profit of €40,551.
Where can I find the annual accounts of Dr. Ilse Van Genechten?
Dr. Ilse Van Genechten filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Ilse Van Genechten due?
Dr. Ilse Van Genechten must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.